Key result
High-dose methylprednisolone and colchicine successfully resolve ICI-induced myopericarditis with concurrent coronary vasospasm.
Case Report (n=1)
No
Coronary vasospasm is a reversible manifestation of immune checkpoint inhibitor-associated myocarditis that can mimic severe multivessel obstructive coronary artery disease and co-occur with multisystem endocrinopathies.
Answers are grounded in this paper and cite their sources.
Clinicians should consider vasospasm mimicking multivessel CAD in ICI cardiotoxicity; this case leaves open optimal immunosuppression for concurrent myopericarditis and endocrinopathy.
BACKGROUND: Immune checkpoint inhibitors (ICIs) are associated with rare but potentially fatal immune-related adverse events, including myocarditis, vasculitis, and hypophysitis. CASE SUMMARY: A 53-year-old man with metastatic clear-cell renal cell carcinoma receiving ipilimumab and nivolumab presented with a clinical picture suggestive of acute coronary syndrome. Coronary angiography showed severe triple-vessel disease without a culprit lesion; repeat angiography demonstrated resolution of coronary lesions, consistent with vasospasm. Cardiac magnetic resonance confirmed ICI-associated myocarditis. Concurrent hypophysitis causing secondary adrenal insufficiency was diagnosed. The patient improved with corticosteroids, with full recovery of cardiac function. DISCUSSION: This case illustrates a rare treatable quadrad of immune-related adverse events-coronary vasospasm, myocarditis, pericarditis, and hypophysitis-and highlights coronary vasospasm as a reversible and underrecognized manifestation of ICI-associated myocarditis. TAKE-HOME MESSAGES: Coronary vasospasm can mimic obstructive coronary disease and should be considered in immune checkpoint inhibitor myocarditis. Multisystem immune-related adverse events, including myocarditis, pericarditis, and hypophysitis, may present simultaneously and require prompt multidisciplinary care.
No takes yet. Share an insight, caveat, or question.
Ali et al. (2026) conducted a case report in Immune checkpoint inhibitor-associated coronary vasospasm, myopericarditis, and hypophysitis (n=1). Methylprednisolone and colchicine was evaluated on Clinical and echocardiographic recovery of cardiac function and resolution of coronary vasospasm. High-dose intravenous methylprednisolone (1 g/day) and colchicine resolved ICI-induced myopericarditis and hypophysitis, while repeat angiography confirmed spontaneous resolution of triple-vessel coronary vasospasm.
Synapse has enriched 10 related papers. Consider them for comparative context: